[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fMOLXSFaqrJoN7orQZ00Su6yzMiuv2nz25qw6OtJ-dTU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":74,"rows":81},"TC Erciyes University",[4],325,false,65,4,35005,11,273,[14,17,19,22,25,27,29,31],{"name":15,"count":16},"Pain",16,{"name":18,"count":11},"Postoperative Pain",{"name":20,"count":21},"Anxiety",10,{"name":23,"count":24},"Aromatherapy",5,{"name":26,"count":24},"Comfort",{"name":28,"count":9},"Prostate Cancer",{"name":30,"count":9},"Hemodialysis",{"name":32,"count":9},"Analgesia",[34,39,44,49,54,59,64,69],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06764004","The Effect of Human Umbilical Cord Mesenchymal Stem Cells and Exosomes on the Healing of Postoperative Pain and Periapical Lesions in the Treatment of Apical Periodontitis: Randomized Controlled Clinical Study","2025-02-01","Stem Cell Product",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06571682","Comparison of Target Controlled Infusion Anesthesia and Inhalation Anesthesia in Pediatric Laparoscopic Surgeries","2025-02-28","Inhalation anesthetic",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06860191","Effect of Different Sealers and Activation Methods on Pain","2025-03-01","Root Canal Sealants",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06784622","Evaluatıon of the Effect of Pulpotomy Treatments Wıth Dıfferent Bıomaterıals on Postoperatıve Paın In Permanent Molars","2025-06-01","Treatment as usual",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT07031895","The Effectiveness of Hyaluronic Acid in Bone Regeneration","2026-04-01","a bovine-derived graft\u002Fxenograft enriched with hyaluronic acid",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07599254","Effect of Two Different Irrigation Protocols and Activation Techniques on Postoperative Pain in Single-visit Endodontic Retreatment: Prospective Randomized Clinical Trial","2026-06-05","root canal irrigation",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT07120204","One Cause of Heel Pain is Plantar Fasciopathy (PF). In Most Cases, a Heel Spur is Frequently Present Alongside PF. We Aim to Evaluate the Efficacy of Corticosteroid Injection and Radiofrequency Ablation, Along With Tissue Elasticity Assessed by Ultrasound, in Patients With Chronic Pain (≥6 Months).","2026-08-15","Corticosteroid",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT07608900","Pre-emptive Local Anesthesia and Sevoflurane Consumption in Pediatric Dental Anesthesia","2027-08","Articaine With Epinephrine",[75,76,77,78,79,80],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[82,107,129,150,170,188,223,257,282,304,322,340,489,539,566,592,618,640,658,676,701,719,737,755,773,791,815,839,857,875,898,916,940,958,976,994,1020,1054,1080,1098,1124,1142,1168,1186,1212,1238,1268,1294,1320,1365,1390,1416,1434,1459,1485,1503,1530,1559,1584,1602,1620],{"intervention":63,"totalTrials":83,"cells":84},1,{"EARLY_PHASE1":85,"PHASE1":88,"PHASE2":90,"PHASE3":92,"PHASE4":94,"NA":105},{"trials":86,"activeCount":87},[],0,{"trials":89,"activeCount":87},[],{"trials":91,"activeCount":87},[],{"trials":93,"activeCount":87},[],{"trials":95,"activeCount":83,"soonestReadout":62},[96],{"nctId":60,"briefTitle":61,"status":97,"phases":98,"primaryCompletion":62,"completion":99,"start":100,"enrollment":101,"conditions":102,"interventions":104},"RECRUITING",[79],"2026-07-15","2025-01-01",100,[103],"Apical Periodontitis",[63],{"trials":106,"activeCount":87},[],{"intervention":48,"totalTrials":83,"cells":108},{"EARLY_PHASE1":109,"PHASE1":111,"PHASE2":113,"PHASE3":115,"PHASE4":117,"NA":127},{"trials":110,"activeCount":87},[],{"trials":112,"activeCount":87},[],{"trials":114,"activeCount":87},[],{"trials":116,"activeCount":87},[],{"trials":118,"activeCount":83,"soonestReadout":47},[119],{"nctId":45,"briefTitle":46,"status":120,"phases":121,"primaryCompletion":47,"completion":122,"start":47,"enrollment":123,"conditions":124,"interventions":126},"NOT_YET_RECRUITING",[79],"2025-05-01",80,[125],"Chronic Apical Periodontitis",[48],{"trials":128,"activeCount":87},[],{"intervention":53,"totalTrials":83,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":148},{"trials":132,"activeCount":87},[],{"trials":134,"activeCount":87},[],{"trials":136,"activeCount":87},[],{"trials":138,"activeCount":87},[],{"trials":140,"activeCount":83,"soonestReadout":52},[141],{"nctId":50,"briefTitle":51,"status":120,"phases":142,"primaryCompletion":52,"completion":143,"start":37,"enrollment":144,"conditions":145,"interventions":147},[79],"2025-07-01",54,[146],"Acute Pulpitis",[53],{"trials":149,"activeCount":87},[],{"intervention":38,"totalTrials":83,"cells":151},{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":164,"PHASE4":166,"NA":168},{"trials":153,"activeCount":87},[],{"trials":155,"activeCount":87},[],{"trials":157,"activeCount":83,"soonestReadout":37},[158],{"nctId":35,"briefTitle":36,"status":120,"phases":159,"primaryCompletion":37,"completion":122,"start":100,"enrollment":160,"conditions":161,"interventions":162},[76,77],45,[103],[38,163],"Bleeding and clots",{"trials":165,"activeCount":87},[],{"trials":167,"activeCount":87},[],{"trials":169,"activeCount":87},[],{"intervention":163,"totalTrials":83,"cells":171},{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":182,"PHASE4":184,"NA":186},{"trials":173,"activeCount":87},[],{"trials":175,"activeCount":87},[],{"trials":177,"activeCount":83,"soonestReadout":37},[178],{"nctId":35,"briefTitle":36,"status":120,"phases":179,"primaryCompletion":37,"completion":122,"start":100,"enrollment":160,"conditions":180,"interventions":181},[76,77],[103],[38,163],{"trials":183,"activeCount":87},[],{"trials":185,"activeCount":87},[],{"trials":187,"activeCount":87},[],{"intervention":43,"totalTrials":189,"cells":190},2,{"EARLY_PHASE1":191,"PHASE1":193,"PHASE2":195,"PHASE3":197,"PHASE4":199,"NA":201},{"trials":192,"activeCount":87},[],{"trials":194,"activeCount":87},[],{"trials":196,"activeCount":87},[],{"trials":198,"activeCount":87},[],{"trials":200,"activeCount":87},[],{"trials":202,"activeCount":83,"soonestReadout":42},[203,212],{"nctId":40,"briefTitle":41,"status":120,"phases":204,"primaryCompletion":42,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":211},[],"2025-03-30","2024-09-15",60,[209,210],"Laparoscopic Surgery","Target Controlled Infusion",[43],{"nctId":213,"briefTitle":214,"status":215,"phases":216,"primaryCompletion":217,"completion":217,"start":218,"enrollment":207,"conditions":219,"interventions":222},"NCT06467279","Comparing Inhalation and Total Intravenous Anesthesia Methods","COMPLETED",[],"2023-12-15","2022-08-15",[220,221],"Children","Hernia, Inguinal",[43],{"intervention":224,"totalTrials":189,"cells":225},"Sevoflurane",{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":232,"PHASE4":234,"NA":248},{"trials":227,"activeCount":87},[],{"trials":229,"activeCount":87},[],{"trials":231,"activeCount":87},[],{"trials":233,"activeCount":87},[],{"trials":235,"activeCount":87},[236],{"nctId":237,"briefTitle":238,"status":215,"phases":239,"primaryCompletion":240,"completion":241,"start":242,"enrollment":207,"conditions":243,"interventions":245},"NCT01955135","Anesthesia for Retinopathy of Prematurity",[79],"2012-12","2013-03","2010-09",[244],"Retinopathy",[246,224,247],"Ketamine","propofol",{"trials":249,"activeCount":83,"soonestReadout":72},[250],{"nctId":70,"briefTitle":71,"status":120,"phases":251,"primaryCompletion":72,"completion":252,"start":253,"enrollment":123,"conditions":254,"interventions":256},[80],"2027-09","2026-08",[255],"Sevoflurane Consumption",[73,224],{"intervention":68,"totalTrials":83,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":269},{"trials":260,"activeCount":87},[],{"trials":262,"activeCount":87},[],{"trials":264,"activeCount":87},[],{"trials":266,"activeCount":87},[],{"trials":268,"activeCount":87},[],{"trials":270,"activeCount":83,"soonestReadout":67},[271],{"nctId":65,"briefTitle":66,"status":120,"phases":272,"primaryCompletion":67,"completion":67,"start":273,"enrollment":274,"conditions":275,"interventions":281},[80],"2025-08-15",50,[276,277,278,279,280],"Plantar Fasciopathy","Chronic Pain","Corticosteroid Injection","Radiofrequency Ablation","Elasticity Imaging Techniques",[68],{"intervention":58,"totalTrials":83,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":294},{"trials":285,"activeCount":87},[],{"trials":287,"activeCount":87},[],{"trials":289,"activeCount":87},[],{"trials":291,"activeCount":87},[],{"trials":293,"activeCount":87},[],{"trials":295,"activeCount":83,"soonestReadout":57},[296],{"nctId":55,"briefTitle":56,"status":120,"phases":297,"primaryCompletion":57,"completion":298,"start":299,"enrollment":207,"conditions":300,"interventions":302},[80],"2026-09-01","2025-09-02",[301],"Socket Preservation",[58,303],"a standart bovine-derived graft\u002Fxenograft",{"intervention":303,"totalTrials":83,"cells":305},{"EARLY_PHASE1":306,"PHASE1":308,"PHASE2":310,"PHASE3":312,"PHASE4":314,"NA":316},{"trials":307,"activeCount":87},[],{"trials":309,"activeCount":87},[],{"trials":311,"activeCount":87},[],{"trials":313,"activeCount":87},[],{"trials":315,"activeCount":87},[],{"trials":317,"activeCount":83,"soonestReadout":57},[318],{"nctId":55,"briefTitle":56,"status":120,"phases":319,"primaryCompletion":57,"completion":298,"start":299,"enrollment":207,"conditions":320,"interventions":321},[80],[301],[58,303],{"intervention":73,"totalTrials":83,"cells":323},{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":330,"PHASE4":332,"NA":334},{"trials":325,"activeCount":87},[],{"trials":327,"activeCount":87},[],{"trials":329,"activeCount":87},[],{"trials":331,"activeCount":87},[],{"trials":333,"activeCount":87},[],{"trials":335,"activeCount":83,"soonestReadout":72},[336],{"nctId":70,"briefTitle":71,"status":120,"phases":337,"primaryCompletion":72,"completion":252,"start":253,"enrollment":123,"conditions":338,"interventions":339},[80],[255],[73,224],{"intervention":341,"totalTrials":342,"cells":343},"Dexmedetomidine",13,{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":350,"PHASE4":352,"NA":487},{"trials":345,"activeCount":87},[],{"trials":347,"activeCount":87},[],{"trials":349,"activeCount":87},[],{"trials":351,"activeCount":87},[],{"trials":353,"activeCount":87},[354,366,376,387,398,409,420,431,444,453,461,469,477],{"nctId":355,"briefTitle":356,"status":215,"phases":357,"primaryCompletion":358,"completion":359,"start":360,"enrollment":207,"conditions":361,"interventions":364},"NCT01948336","The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients",[79],"2013-04","2013-08","2012-04",[362,363],"Renal Function Disorder","Hemodynamic Instability",[341,246,365],"Propofol",{"nctId":367,"briefTitle":368,"status":215,"phases":369,"primaryCompletion":241,"completion":370,"start":371,"enrollment":207,"conditions":372,"interventions":374},"NCT01956981","Controlled Hypotension During Functional Endoscopic Sinus Surgery",[79],"2013-07","2012-01",[373],"Hemorrhage",[375,341],"Magnesium Sulfate",{"nctId":377,"briefTitle":378,"status":215,"phases":379,"primaryCompletion":380,"completion":381,"start":241,"enrollment":207,"conditions":382,"interventions":384},"NCT01964586","Comparison of Preincisional Infiltrated Dexmedetomidine and Lidocaine Plus Adrenaline for Nasal Sephoplasty Surgery.",[79],"2013-09","2013-10",[383,15],"Surgery",[341,385,386],"Lidocaine","Adrenaline",{"nctId":388,"briefTitle":389,"status":215,"phases":390,"primaryCompletion":391,"completion":391,"start":392,"enrollment":393,"conditions":394,"interventions":395},"NCT02064530","Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block",[79],"2015-09","2014-02",90,[15],[396,341,397],"Bupivacaine","serum physiologic",{"nctId":399,"briefTitle":400,"status":215,"phases":401,"primaryCompletion":402,"completion":403,"start":404,"enrollment":207,"conditions":405,"interventions":407},"NCT02137863","Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy",[79],"2012-06","2012-07","2011-06",[406],"Radiographic Contrast Agent Nephropathy",[341,408,408],"0.9 % NaCl",{"nctId":410,"briefTitle":411,"status":215,"phases":412,"primaryCompletion":371,"completion":371,"start":413,"enrollment":414,"conditions":415,"interventions":417},"NCT01921361","The Effects of Dexmedetomidine on Peroperative Shivering Incidence Under Spinal Anesthesia",[79],"2011-01",120,[416],"Perioperative\u002FPostoperative Complications",[418,341,341,419],"Levobupivacaine","sodium chloride",{"nctId":421,"briefTitle":422,"status":423,"phases":424,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":428,"interventions":429},"NCT02092012","Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on Abdominal Hysterectomy Patients","UNKNOWN",[79],"2014-06","2014-07","2014-03",[15],[430,341],"dexketoprofen trometamol",{"nctId":432,"briefTitle":433,"status":215,"phases":434,"primaryCompletion":435,"completion":435,"start":436,"enrollment":437,"conditions":438,"interventions":442},"NCT02062333","The Effects of the Drugs Used in Hypotensive Anaesthesia on Cochlea",[79],"2014-11","2014-01",47,[439,440,441],"Anesthesia; Adverse Effect","Reflex, Abnormal","Tinnitus, Spontaneous Oto-Acoustic Emission",[341,443],"esmolol",{"nctId":445,"briefTitle":446,"status":215,"phases":447,"primaryCompletion":448,"completion":448,"start":380,"enrollment":449,"conditions":450,"interventions":452},"NCT02013570","Efficacy of Peritonsillar Dexmedetomidine Infiltration for Postadenotonsillectomy Pain",[79],"2013-12",71,[451],"Pain Postoperative, Intraoperative Hemorrhage",[341],{"nctId":454,"briefTitle":455,"status":215,"phases":456,"primaryCompletion":425,"completion":425,"start":392,"enrollment":207,"conditions":457,"interventions":460},"NCT02072083","Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients",[79],[458,459],"Premedication","Oculocardiac Reflex",[341,246],{"nctId":462,"briefTitle":463,"status":215,"phases":464,"primaryCompletion":465,"completion":466,"start":465,"enrollment":274,"conditions":467,"interventions":468},"NCT01929252","Postoperative Analgesic Effect Of Dexmedetomidine Administration in Wound Infiltration for Total Abdominal Hysterectomy",[79],"2011-08","2012-08",[15],[341,418],{"nctId":470,"briefTitle":471,"status":215,"phases":472,"primaryCompletion":240,"completion":240,"start":473,"enrollment":207,"conditions":474,"interventions":475},"NCT01918917","Adding Intra-articular Dexmedetomidine to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery",[79],"2011-07",[15],[418,341,476],"Morphine",{"nctId":478,"briefTitle":479,"status":215,"phases":480,"primaryCompletion":435,"completion":435,"start":436,"enrollment":481,"conditions":482,"interventions":484},"NCT02049970","Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade",[79],44,[483],"Sequelae of Fracture of Forearm and Upper Arm",[485,486],"dexmedetomidine","bupivacaine",{"trials":488,"activeCount":87},[],{"intervention":397,"totalTrials":24,"cells":490},{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":497,"PHASE4":499,"NA":537},{"trials":492,"activeCount":87},[],{"trials":494,"activeCount":87},[],{"trials":496,"activeCount":87},[],{"trials":498,"activeCount":87},[],{"trials":500,"activeCount":87},[501,509,513,521,528],{"nctId":502,"briefTitle":503,"status":423,"phases":504,"primaryCompletion":505,"completion":505,"start":435,"enrollment":393,"conditions":506,"interventions":507},"NCT02160236","Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam",[79],"2015-02",[18],[430,508,397],"tenoxicam",{"nctId":388,"briefTitle":389,"status":215,"phases":510,"primaryCompletion":391,"completion":391,"start":392,"enrollment":393,"conditions":511,"interventions":512},[79],[15],[396,341,397],{"nctId":514,"briefTitle":515,"status":423,"phases":516,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":517,"interventions":518},"NCT02090790","Comparison of Analgesic Consumption Between Perioperative ıv Dexamethasone and Added to Femoral Block",[79],[18],[519,520,397],"iv dexamethasone","femoral dexamethasone",{"nctId":522,"briefTitle":523,"status":423,"phases":524,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":525,"interventions":526},"NCT02094066","The Effect of Tranexamic Acid for Total Hip Arthroplasty",[79],[373],[527,397],"tranexamic acid",{"nctId":529,"briefTitle":530,"status":215,"phases":531,"primaryCompletion":532,"completion":532,"start":391,"enrollment":533,"conditions":534,"interventions":535},"NCT02544893","Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block",[79],"2016-03",93,[15],[486,536,397],"dexmedetomidin",{"trials":538,"activeCount":87},[],{"intervention":246,"totalTrials":540,"cells":541},3,{"EARLY_PHASE1":542,"PHASE1":544,"PHASE2":546,"PHASE3":548,"PHASE4":550,"NA":564},{"trials":543,"activeCount":87},[],{"trials":545,"activeCount":87},[],{"trials":547,"activeCount":87},[],{"trials":549,"activeCount":87},[],{"trials":551,"activeCount":87},[552,556,560],{"nctId":355,"briefTitle":356,"status":215,"phases":553,"primaryCompletion":358,"completion":359,"start":360,"enrollment":207,"conditions":554,"interventions":555},[79],[362,363],[341,246,365],{"nctId":454,"briefTitle":455,"status":215,"phases":557,"primaryCompletion":425,"completion":425,"start":392,"enrollment":207,"conditions":558,"interventions":559},[79],[458,459],[341,246],{"nctId":237,"briefTitle":238,"status":215,"phases":561,"primaryCompletion":240,"completion":241,"start":242,"enrollment":207,"conditions":562,"interventions":563},[79],[244],[246,224,247],{"trials":565,"activeCount":87},[],{"intervention":486,"totalTrials":540,"cells":567},{"EARLY_PHASE1":568,"PHASE1":570,"PHASE2":572,"PHASE3":574,"PHASE4":576,"NA":590},{"trials":569,"activeCount":87},[],{"trials":571,"activeCount":87},[],{"trials":573,"activeCount":87},[],{"trials":575,"activeCount":87},[],{"trials":577,"activeCount":87},[578,582,586],{"nctId":388,"briefTitle":389,"status":215,"phases":579,"primaryCompletion":391,"completion":391,"start":392,"enrollment":393,"conditions":580,"interventions":581},[79],[15],[396,341,397],{"nctId":478,"briefTitle":479,"status":215,"phases":583,"primaryCompletion":435,"completion":435,"start":436,"enrollment":481,"conditions":584,"interventions":585},[79],[483],[485,486],{"nctId":529,"briefTitle":530,"status":215,"phases":587,"primaryCompletion":532,"completion":532,"start":391,"enrollment":533,"conditions":588,"interventions":589},[79],[15],[486,536,397],{"trials":591,"activeCount":87},[],{"intervention":418,"totalTrials":540,"cells":593},{"EARLY_PHASE1":594,"PHASE1":596,"PHASE2":598,"PHASE3":600,"PHASE4":602,"NA":616},{"trials":595,"activeCount":87},[],{"trials":597,"activeCount":87},[],{"trials":599,"activeCount":87},[],{"trials":601,"activeCount":87},[],{"trials":603,"activeCount":87},[604,608,612],{"nctId":410,"briefTitle":411,"status":215,"phases":605,"primaryCompletion":371,"completion":371,"start":413,"enrollment":414,"conditions":606,"interventions":607},[79],[416],[418,341,341,419],{"nctId":462,"briefTitle":463,"status":215,"phases":609,"primaryCompletion":465,"completion":466,"start":465,"enrollment":274,"conditions":610,"interventions":611},[79],[15],[341,418],{"nctId":470,"briefTitle":471,"status":215,"phases":613,"primaryCompletion":240,"completion":240,"start":473,"enrollment":207,"conditions":614,"interventions":615},[79],[15],[418,341,476],{"trials":617,"activeCount":87},[],{"intervention":430,"totalTrials":189,"cells":619},{"EARLY_PHASE1":620,"PHASE1":622,"PHASE2":624,"PHASE3":626,"PHASE4":628,"NA":638},{"trials":621,"activeCount":87},[],{"trials":623,"activeCount":87},[],{"trials":625,"activeCount":87},[],{"trials":627,"activeCount":87},[],{"trials":629,"activeCount":87},[630,634],{"nctId":502,"briefTitle":503,"status":423,"phases":631,"primaryCompletion":505,"completion":505,"start":435,"enrollment":393,"conditions":632,"interventions":633},[79],[18],[430,508,397],{"nctId":421,"briefTitle":422,"status":423,"phases":635,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":636,"interventions":637},[79],[15],[430,341],{"trials":639,"activeCount":87},[],{"intervention":508,"totalTrials":83,"cells":641},{"EARLY_PHASE1":642,"PHASE1":644,"PHASE2":646,"PHASE3":648,"PHASE4":650,"NA":656},{"trials":643,"activeCount":87},[],{"trials":645,"activeCount":87},[],{"trials":647,"activeCount":87},[],{"trials":649,"activeCount":87},[],{"trials":651,"activeCount":87},[652],{"nctId":502,"briefTitle":503,"status":423,"phases":653,"primaryCompletion":505,"completion":505,"start":435,"enrollment":393,"conditions":654,"interventions":655},[79],[18],[430,508,397],{"trials":657,"activeCount":87},[],{"intervention":375,"totalTrials":83,"cells":659},{"EARLY_PHASE1":660,"PHASE1":662,"PHASE2":664,"PHASE3":666,"PHASE4":668,"NA":674},{"trials":661,"activeCount":87},[],{"trials":663,"activeCount":87},[],{"trials":665,"activeCount":87},[],{"trials":667,"activeCount":87},[],{"trials":669,"activeCount":87},[670],{"nctId":367,"briefTitle":368,"status":215,"phases":671,"primaryCompletion":241,"completion":370,"start":371,"enrollment":207,"conditions":672,"interventions":673},[79],[373],[375,341],{"trials":675,"activeCount":87},[],{"intervention":677,"totalTrials":83,"cells":678},"Atomoxetine",{"EARLY_PHASE1":679,"PHASE1":681,"PHASE2":683,"PHASE3":685,"PHASE4":687,"NA":699},{"trials":680,"activeCount":87},[],{"trials":682,"activeCount":87},[],{"trials":684,"activeCount":87},[],{"trials":686,"activeCount":87},[],{"trials":688,"activeCount":87},[689],{"nctId":690,"briefTitle":691,"status":215,"phases":692,"primaryCompletion":693,"completion":693,"start":392,"enrollment":694,"conditions":695,"interventions":697},"NCT02352051","Effects of Atx and Oros-mph on Executive Functions",[79],"2014-10",43,[696],"Executive Dysfunction",[677,698],"methylphenidate",{"trials":700,"activeCount":87},[],{"intervention":698,"totalTrials":83,"cells":702},{"EARLY_PHASE1":703,"PHASE1":705,"PHASE2":707,"PHASE3":709,"PHASE4":711,"NA":717},{"trials":704,"activeCount":87},[],{"trials":706,"activeCount":87},[],{"trials":708,"activeCount":87},[],{"trials":710,"activeCount":87},[],{"trials":712,"activeCount":87},[713],{"nctId":690,"briefTitle":691,"status":215,"phases":714,"primaryCompletion":693,"completion":693,"start":392,"enrollment":694,"conditions":715,"interventions":716},[79],[696],[677,698],{"trials":718,"activeCount":87},[],{"intervention":385,"totalTrials":83,"cells":720},{"EARLY_PHASE1":721,"PHASE1":723,"PHASE2":725,"PHASE3":727,"PHASE4":729,"NA":735},{"trials":722,"activeCount":87},[],{"trials":724,"activeCount":87},[],{"trials":726,"activeCount":87},[],{"trials":728,"activeCount":87},[],{"trials":730,"activeCount":87},[731],{"nctId":377,"briefTitle":378,"status":215,"phases":732,"primaryCompletion":380,"completion":381,"start":241,"enrollment":207,"conditions":733,"interventions":734},[79],[383,15],[341,385,386],{"trials":736,"activeCount":87},[],{"intervention":386,"totalTrials":83,"cells":738},{"EARLY_PHASE1":739,"PHASE1":741,"PHASE2":743,"PHASE3":745,"PHASE4":747,"NA":753},{"trials":740,"activeCount":87},[],{"trials":742,"activeCount":87},[],{"trials":744,"activeCount":87},[],{"trials":746,"activeCount":87},[],{"trials":748,"activeCount":87},[749],{"nctId":377,"briefTitle":378,"status":215,"phases":750,"primaryCompletion":380,"completion":381,"start":241,"enrollment":207,"conditions":751,"interventions":752},[79],[383,15],[341,385,386],{"trials":754,"activeCount":87},[],{"intervention":408,"totalTrials":83,"cells":756},{"EARLY_PHASE1":757,"PHASE1":759,"PHASE2":761,"PHASE3":763,"PHASE4":765,"NA":771},{"trials":758,"activeCount":87},[],{"trials":760,"activeCount":87},[],{"trials":762,"activeCount":87},[],{"trials":764,"activeCount":87},[],{"trials":766,"activeCount":87},[767],{"nctId":399,"briefTitle":400,"status":215,"phases":768,"primaryCompletion":402,"completion":403,"start":404,"enrollment":207,"conditions":769,"interventions":770},[79],[406],[341,408,408],{"trials":772,"activeCount":87},[],{"intervention":419,"totalTrials":83,"cells":774},{"EARLY_PHASE1":775,"PHASE1":777,"PHASE2":779,"PHASE3":781,"PHASE4":783,"NA":789},{"trials":776,"activeCount":87},[],{"trials":778,"activeCount":87},[],{"trials":780,"activeCount":87},[],{"trials":782,"activeCount":87},[],{"trials":784,"activeCount":87},[785],{"nctId":410,"briefTitle":411,"status":215,"phases":786,"primaryCompletion":371,"completion":371,"start":413,"enrollment":414,"conditions":787,"interventions":788},[79],[416],[418,341,341,419],{"trials":790,"activeCount":87},[],{"intervention":792,"totalTrials":83,"cells":793},"Amantadine Sulfate",{"EARLY_PHASE1":794,"PHASE1":796,"PHASE2":798,"PHASE3":800,"PHASE4":802,"NA":813},{"trials":795,"activeCount":87},[],{"trials":797,"activeCount":87},[],{"trials":799,"activeCount":87},[],{"trials":801,"activeCount":87},[],{"trials":803,"activeCount":87},[804],{"nctId":805,"briefTitle":806,"status":423,"phases":807,"primaryCompletion":808,"completion":808,"start":809,"enrollment":144,"conditions":810,"interventions":812},"NCT03988010","Evaluation of the Effect of Preoperative Intravenous Amantadine Sulfate on the Postoperative Early Cognitive Functions in a Elderly Patient With Laparoscopic Radical Prostatectomy",[79],"2019-12-01","2019-05-01",[811],"Postoperative Cognitive Dysfunction",[792],{"trials":814,"activeCount":87},[],{"intervention":816,"totalTrials":83,"cells":817},"Indocyanine green",{"EARLY_PHASE1":818,"PHASE1":820,"PHASE2":822,"PHASE3":824,"PHASE4":826,"NA":837},{"trials":819,"activeCount":87},[],{"trials":821,"activeCount":87},[],{"trials":823,"activeCount":87},[],{"trials":825,"activeCount":87},[],{"trials":827,"activeCount":87},[828],{"nctId":829,"briefTitle":830,"status":423,"phases":831,"primaryCompletion":832,"completion":832,"start":833,"enrollment":274,"conditions":834,"interventions":836},"NCT04882618","Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.",[79],"2021-11-08","2019-11-08",[28,835],"Lymph Node Metastases",[816],{"trials":838,"activeCount":87},[],{"intervention":519,"totalTrials":83,"cells":840},{"EARLY_PHASE1":841,"PHASE1":843,"PHASE2":845,"PHASE3":847,"PHASE4":849,"NA":855},{"trials":842,"activeCount":87},[],{"trials":844,"activeCount":87},[],{"trials":846,"activeCount":87},[],{"trials":848,"activeCount":87},[],{"trials":850,"activeCount":87},[851],{"nctId":514,"briefTitle":515,"status":423,"phases":852,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":853,"interventions":854},[79],[18],[519,520,397],{"trials":856,"activeCount":87},[],{"intervention":520,"totalTrials":83,"cells":858},{"EARLY_PHASE1":859,"PHASE1":861,"PHASE2":863,"PHASE3":865,"PHASE4":867,"NA":873},{"trials":860,"activeCount":87},[],{"trials":862,"activeCount":87},[],{"trials":864,"activeCount":87},[],{"trials":866,"activeCount":87},[],{"trials":868,"activeCount":87},[869],{"nctId":514,"briefTitle":515,"status":423,"phases":870,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":871,"interventions":872},[79],[18],[519,520,397],{"trials":874,"activeCount":87},[],{"intervention":876,"totalTrials":83,"cells":877},"Tirofiban",{"EARLY_PHASE1":878,"PHASE1":880,"PHASE2":882,"PHASE3":884,"PHASE4":886,"NA":896},{"trials":879,"activeCount":87},[],{"trials":881,"activeCount":87},[],{"trials":883,"activeCount":87},[],{"trials":885,"activeCount":87},[],{"trials":887,"activeCount":87},[888],{"nctId":889,"briefTitle":890,"status":215,"phases":891,"primaryCompletion":448,"completion":448,"start":413,"enrollment":892,"conditions":893,"interventions":895},"NCT02054000","Intracoronary Tirofiban on No-Reflow Phenomena",[79],162,[894],"No-Reflow Phenomenon",[876],{"trials":897,"activeCount":87},[],{"intervention":443,"totalTrials":83,"cells":899},{"EARLY_PHASE1":900,"PHASE1":902,"PHASE2":904,"PHASE3":906,"PHASE4":908,"NA":914},{"trials":901,"activeCount":87},[],{"trials":903,"activeCount":87},[],{"trials":905,"activeCount":87},[],{"trials":907,"activeCount":87},[],{"trials":909,"activeCount":87},[910],{"nctId":432,"briefTitle":433,"status":215,"phases":911,"primaryCompletion":435,"completion":435,"start":436,"enrollment":437,"conditions":912,"interventions":913},[79],[439,440,441],[341,443],{"trials":915,"activeCount":87},[],{"intervention":917,"totalTrials":83,"cells":918},"Spironolactone",{"EARLY_PHASE1":919,"PHASE1":921,"PHASE2":923,"PHASE3":925,"PHASE4":927,"NA":938},{"trials":920,"activeCount":87},[],{"trials":922,"activeCount":87},[],{"trials":924,"activeCount":87},[],{"trials":926,"activeCount":87},[],{"trials":928,"activeCount":87},[929],{"nctId":930,"briefTitle":931,"status":215,"phases":932,"primaryCompletion":933,"completion":933,"start":934,"enrollment":393,"conditions":935,"interventions":937},"NCT02053974","Spironolactone Against Anthracycline-induced Cardiomyopathy",[79],"2012-10","2011-09",[936],"Anthracycline Induced Cardiotoxicity",[917],{"trials":939,"activeCount":87},[],{"intervention":527,"totalTrials":83,"cells":941},{"EARLY_PHASE1":942,"PHASE1":944,"PHASE2":946,"PHASE3":948,"PHASE4":950,"NA":956},{"trials":943,"activeCount":87},[],{"trials":945,"activeCount":87},[],{"trials":947,"activeCount":87},[],{"trials":949,"activeCount":87},[],{"trials":951,"activeCount":87},[952],{"nctId":522,"briefTitle":523,"status":423,"phases":953,"primaryCompletion":425,"completion":426,"start":427,"enrollment":207,"conditions":954,"interventions":955},[79],[373],[527,397],{"trials":957,"activeCount":87},[],{"intervention":476,"totalTrials":83,"cells":959},{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":968,"NA":974},{"trials":961,"activeCount":87},[],{"trials":963,"activeCount":87},[],{"trials":965,"activeCount":87},[],{"trials":967,"activeCount":87},[],{"trials":969,"activeCount":87},[970],{"nctId":470,"briefTitle":471,"status":215,"phases":971,"primaryCompletion":240,"completion":240,"start":473,"enrollment":207,"conditions":972,"interventions":973},[79],[15],[418,341,476],{"trials":975,"activeCount":87},[],{"intervention":536,"totalTrials":83,"cells":977},{"EARLY_PHASE1":978,"PHASE1":980,"PHASE2":982,"PHASE3":984,"PHASE4":986,"NA":992},{"trials":979,"activeCount":87},[],{"trials":981,"activeCount":87},[],{"trials":983,"activeCount":87},[],{"trials":985,"activeCount":87},[],{"trials":987,"activeCount":87},[988],{"nctId":529,"briefTitle":530,"status":215,"phases":989,"primaryCompletion":532,"completion":532,"start":391,"enrollment":533,"conditions":990,"interventions":991},[79],[15],[486,536,397],{"trials":993,"activeCount":87},[],{"intervention":995,"totalTrials":83,"cells":996},"Prednisolone",{"EARLY_PHASE1":997,"PHASE1":999,"PHASE2":1001,"PHASE3":1003,"PHASE4":1005,"NA":1018},{"trials":998,"activeCount":87},[],{"trials":1000,"activeCount":87},[],{"trials":1002,"activeCount":87},[],{"trials":1004,"activeCount":87},[],{"trials":1006,"activeCount":87},[1007],{"nctId":1008,"briefTitle":1009,"status":215,"phases":1010,"primaryCompletion":1011,"completion":1012,"start":1013,"enrollment":1014,"conditions":1015,"interventions":1017},"NCT01275638","The Effect of Moderate-Dose Steroid Therapy in Sepsis",[79],"2008-05","2009-05","2005-04",55,[1016],"Sepsis",[995],{"trials":1019,"activeCount":87},[],{"intervention":1021,"totalTrials":189,"cells":1022},"N-acetylcysteine",{"EARLY_PHASE1":1023,"PHASE1":1025,"PHASE2":1027,"PHASE3":1039,"PHASE4":1050,"NA":1052},{"trials":1024,"activeCount":87},[],{"trials":1026,"activeCount":87},[],{"trials":1028,"activeCount":87},[1029],{"nctId":1030,"briefTitle":1031,"status":215,"phases":1032,"primaryCompletion":1033,"completion":1034,"start":1035,"enrollment":207,"conditions":1036,"interventions":1038},"NCT01131468","Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine",[77],"2010-04","2010-05","2008-02",[1037],"Drug-induced Ototoxicity in Peritoneal Dialysis Patients",[1021],{"trials":1040,"activeCount":87},[1041],{"nctId":1042,"briefTitle":1043,"status":215,"phases":1044,"primaryCompletion":1045,"completion":1045,"start":1046,"enrollment":207,"conditions":1047,"interventions":1049},"NCT01271088","Protective Effect of N-acetylcysteine Against From Ototoxicity",[77,78],"2011-11","2010-06",[1048],"Hearing Loss, Extreme",[1021],{"trials":1051,"activeCount":87},[],{"trials":1053,"activeCount":87},[],{"intervention":1055,"totalTrials":83,"cells":1056},"Subtenon injection of Wharton jelly derived mesenchymal stem cells",{"EARLY_PHASE1":1057,"PHASE1":1059,"PHASE2":1061,"PHASE3":1063,"PHASE4":1076,"NA":1078},{"trials":1058,"activeCount":87},[],{"trials":1060,"activeCount":87},[],{"trials":1062,"activeCount":87},[],{"trials":1064,"activeCount":87},[1065],{"nctId":1066,"briefTitle":1067,"status":423,"phases":1068,"primaryCompletion":1069,"completion":217,"start":1070,"enrollment":1071,"conditions":1072,"interventions":1074},"NCT05413148","The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa",[77,78],"2023-07-01","2022-08-05",135,[1073],"Retinitis Pigmentosa",[1055,1075],"Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes",{"trials":1077,"activeCount":87},[],{"trials":1079,"activeCount":87},[],{"intervention":1075,"totalTrials":83,"cells":1081},{"EARLY_PHASE1":1082,"PHASE1":1084,"PHASE2":1086,"PHASE3":1088,"PHASE4":1094,"NA":1096},{"trials":1083,"activeCount":87},[],{"trials":1085,"activeCount":87},[],{"trials":1087,"activeCount":87},[],{"trials":1089,"activeCount":87},[1090],{"nctId":1066,"briefTitle":1067,"status":423,"phases":1091,"primaryCompletion":1069,"completion":217,"start":1070,"enrollment":1071,"conditions":1092,"interventions":1093},[77,78],[1073],[1055,1075],{"trials":1095,"activeCount":87},[],{"trials":1097,"activeCount":87},[],{"intervention":1099,"totalTrials":83,"cells":1100},"Lidocaine Spray: Each ml contained 10 mg lidocaine and ethanol. Applied to the local site to provide anesthesia",{"EARLY_PHASE1":1101,"PHASE1":1103,"PHASE2":1105,"PHASE3":1107,"PHASE4":1120,"NA":1122},{"trials":1102,"activeCount":87},[],{"trials":1104,"activeCount":87},[],{"trials":1106,"activeCount":87},[],{"trials":1108,"activeCount":87},[1109],{"nctId":1110,"briefTitle":1111,"status":215,"phases":1112,"primaryCompletion":1113,"completion":1113,"start":1114,"enrollment":207,"conditions":1115,"interventions":1118},"NCT07242157","Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction",[78],"2024-06-01","2024-04-01",[15,1116,30,1117],"Satisfaction","Arteriovenous Fistula",[1099,1119],"Benzocaine spray",{"trials":1121,"activeCount":87},[],{"trials":1123,"activeCount":87},[],{"intervention":1119,"totalTrials":83,"cells":1125},{"EARLY_PHASE1":1126,"PHASE1":1128,"PHASE2":1130,"PHASE3":1132,"PHASE4":1138,"NA":1140},{"trials":1127,"activeCount":87},[],{"trials":1129,"activeCount":87},[],{"trials":1131,"activeCount":87},[],{"trials":1133,"activeCount":87},[1134],{"nctId":1110,"briefTitle":1111,"status":215,"phases":1135,"primaryCompletion":1113,"completion":1113,"start":1114,"enrollment":207,"conditions":1136,"interventions":1137},[78],[15,1116,30,1117],[1099,1119],{"trials":1139,"activeCount":87},[],{"trials":1141,"activeCount":87},[],{"intervention":1143,"totalTrials":83,"cells":1144},"Lidocaine Spray",{"EARLY_PHASE1":1145,"PHASE1":1147,"PHASE2":1149,"PHASE3":1151,"PHASE4":1164,"NA":1166},{"trials":1146,"activeCount":87},[],{"trials":1148,"activeCount":87},[],{"trials":1150,"activeCount":87},[],{"trials":1152,"activeCount":87},[1153],{"nctId":1154,"briefTitle":1155,"status":215,"phases":1156,"primaryCompletion":1157,"completion":1158,"start":1159,"enrollment":414,"conditions":1160,"interventions":1162},"NCT04859738","The Effect of Lidocaine and Benzocaine on Pain and Injection Satisfaction in Peripheral Intravenous Catheter Application",[78],"2020-07-07","2020-10-20","2020-03-04",[1161],"Peripheral Intravenous Catheterization Application",[1143,1163],"Benzokain Sprey",{"trials":1165,"activeCount":87},[],{"trials":1167,"activeCount":87},[],{"intervention":1163,"totalTrials":83,"cells":1169},{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1176,"PHASE4":1182,"NA":1184},{"trials":1171,"activeCount":87},[],{"trials":1173,"activeCount":87},[],{"trials":1175,"activeCount":87},[],{"trials":1177,"activeCount":87},[1178],{"nctId":1154,"briefTitle":1155,"status":215,"phases":1179,"primaryCompletion":1157,"completion":1158,"start":1159,"enrollment":414,"conditions":1180,"interventions":1181},[78],[1161],[1143,1163],{"trials":1183,"activeCount":87},[],{"trials":1185,"activeCount":87},[],{"intervention":1187,"totalTrials":83,"cells":1188},"Mesenchymal stem cells",{"EARLY_PHASE1":1189,"PHASE1":1191,"PHASE2":1193,"PHASE3":1206,"PHASE4":1208,"NA":1210},{"trials":1190,"activeCount":87},[],{"trials":1192,"activeCount":87},[],{"trials":1194,"activeCount":87},[1195],{"nctId":1196,"briefTitle":1197,"status":215,"phases":1198,"primaryCompletion":1199,"completion":1200,"start":1201,"enrollment":1202,"conditions":1203,"interventions":1205},"NCT05283317","Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock",[76,77],"2019-08-25","2019-11-13","2018-03-11",30,[1016,1204],"Septic Shock",[1187],{"trials":1207,"activeCount":87},[],{"trials":1209,"activeCount":87},[],{"trials":1211,"activeCount":87},[],{"intervention":1213,"totalTrials":83,"cells":1214},"Wharton Jelly Originated Mesencimal Stem Cell",{"EARLY_PHASE1":1215,"PHASE1":1217,"PHASE2":1219,"PHASE3":1232,"PHASE4":1234,"NA":1236},{"trials":1216,"activeCount":87},[],{"trials":1218,"activeCount":87},[],{"trials":1220,"activeCount":87},[1221],{"nctId":1222,"briefTitle":1223,"status":423,"phases":1224,"primaryCompletion":1225,"completion":1226,"start":1227,"enrollment":11,"conditions":1228,"interventions":1231},"NCT04313894","WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS",[77],"2019-12-31","2020-12-31","2019-01-01",[1229,1230],"Stem Cell","Gonarthrosis",[1213],{"trials":1233,"activeCount":87},[],{"trials":1235,"activeCount":87},[],{"trials":1237,"activeCount":87},[],{"intervention":1239,"totalTrials":83,"cells":1240},"Stem Cells",{"EARLY_PHASE1":1241,"PHASE1":1243,"PHASE2":1245,"PHASE3":1262,"PHASE4":1264,"NA":1266},{"trials":1242,"activeCount":87},[],{"trials":1244,"activeCount":87},[],{"trials":1246,"activeCount":87},[1247],{"nctId":1248,"briefTitle":1249,"status":423,"phases":1250,"primaryCompletion":1251,"completion":1252,"start":1253,"enrollment":1254,"conditions":1255,"interventions":1261},"NCT05305833","Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease",[76,77],"2022-12-01","2023-12-01","2021-10-01",20,[1256,1257,1258,1259,1260],"Temporomandibular Joint Disorders","Temporomandibular Disorder","Temporomandibular Joint Osteoarthritis","Temporomandibular Joint Pain","Temporomandibular Joint Effusion",[1239],{"trials":1263,"activeCount":87},[],{"trials":1265,"activeCount":87},[],{"trials":1267,"activeCount":87},[],{"intervention":1269,"totalTrials":83,"cells":1270},"GN037",{"EARLY_PHASE1":1271,"PHASE1":1273,"PHASE2":1286,"PHASE3":1288,"PHASE4":1290,"NA":1292},{"trials":1272,"activeCount":87},[],{"trials":1274,"activeCount":87},[1275],{"nctId":1276,"briefTitle":1277,"status":215,"phases":1278,"primaryCompletion":1279,"completion":1280,"start":1281,"enrollment":1282,"conditions":1283,"interventions":1285},"NCT05428202","Phase I Study of GN-037 Cream for Psoriasis",[76],"2022-04-28","2022-09-30","2022-03-28",24,[1284],"Psoriasis",[1269],{"trials":1287,"activeCount":87},[],{"trials":1289,"activeCount":87},[],{"trials":1291,"activeCount":87},[],{"trials":1293,"activeCount":87},[],{"intervention":1295,"totalTrials":83,"cells":1296},"COVID-19 Specific T Cell derived exosomes",{"EARLY_PHASE1":1297,"PHASE1":1299,"PHASE2":1312,"PHASE3":1314,"PHASE4":1316,"NA":1318},{"trials":1298,"activeCount":87},[],{"trials":1300,"activeCount":87},[1301],{"nctId":1302,"briefTitle":1303,"status":423,"phases":1304,"primaryCompletion":1305,"completion":1306,"start":1307,"enrollment":207,"conditions":1308,"interventions":1311},"NCT04389385","COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo)",[76],"2020-09-30","2021-05-31","2020-05-01",[1309,1310],"Corona Virus Infection","Pneumonia",[1295],{"trials":1313,"activeCount":87},[],{"trials":1315,"activeCount":87},[],{"trials":1317,"activeCount":87},[],{"trials":1319,"activeCount":87},[],{"intervention":365,"totalTrials":9,"cells":1321},{"EARLY_PHASE1":1322,"PHASE1":1324,"PHASE2":1326,"PHASE3":1328,"PHASE4":1330,"NA":1349},{"trials":1323,"activeCount":87},[],{"trials":1325,"activeCount":87},[],{"trials":1327,"activeCount":87},[],{"trials":1329,"activeCount":87},[],{"trials":1331,"activeCount":87},[1332,1336,1345],{"nctId":355,"briefTitle":356,"status":215,"phases":1333,"primaryCompletion":358,"completion":359,"start":360,"enrollment":207,"conditions":1334,"interventions":1335},[79],[362,363],[341,246,365],{"nctId":1337,"briefTitle":1338,"status":215,"phases":1339,"primaryCompletion":1340,"completion":1340,"start":435,"enrollment":1341,"conditions":1342,"interventions":1344},"NCT02271542","Identification of Polymorphisms Involved in the Metabolism of Propofol",[79],"2016-04",300,[1343],"UGT1A1*28 Polymorphism",[247],{"nctId":237,"briefTitle":238,"status":215,"phases":1346,"primaryCompletion":240,"completion":241,"start":242,"enrollment":207,"conditions":1347,"interventions":1348},[79],[244],[246,224,247],{"trials":1350,"activeCount":87},[1351],{"nctId":1352,"briefTitle":1353,"status":423,"phases":1354,"primaryCompletion":1355,"completion":1356,"start":1357,"enrollment":1358,"conditions":1359,"interventions":1361},"NCT03424356","Effects of Low Dose Neuromuscular Blocker Usage on Laryngeal Mask Application",[80],"2018-12-04","2018-12-10","2017-01-04",96,[1360],"Anesthesia",[1362,1363,1364,365],"Rocuronium Bromide","Saline Solution","Fentanyl",{"intervention":1366,"totalTrials":83,"cells":1367},"Oral care with a solution containing 0.2% chlorhexidine gluconate a frequency determined according to the results of the Intensive Care Oral Care Frequency Rating Scale.",{"EARLY_PHASE1":1368,"PHASE1":1370,"PHASE2":1372,"PHASE3":1374,"PHASE4":1376,"NA":1378},{"trials":1369,"activeCount":87},[],{"trials":1371,"activeCount":87},[],{"trials":1373,"activeCount":87},[],{"trials":1375,"activeCount":87},[],{"trials":1377,"activeCount":87},[],{"trials":1379,"activeCount":87},[1380],{"nctId":1381,"briefTitle":1382,"status":215,"phases":1383,"primaryCompletion":1384,"completion":1384,"start":1385,"enrollment":1386,"conditions":1387,"interventions":1389},"NCT06521112","The Effect of Oral Care on Mucositis and Oral Mucosa According to Individual Oral Care Frequency Assessment",[80],"2023-07-12","2023-05-27",41,[1388],"Mucositis",[1366],{"intervention":1391,"totalTrials":83,"cells":1392},"iv dexketoprofen trometamol",{"EARLY_PHASE1":1393,"PHASE1":1395,"PHASE2":1397,"PHASE3":1399,"PHASE4":1401,"NA":1403},{"trials":1394,"activeCount":87},[],{"trials":1396,"activeCount":87},[],{"trials":1398,"activeCount":87},[],{"trials":1400,"activeCount":87},[],{"trials":1402,"activeCount":87},[],{"trials":1404,"activeCount":87},[1405],{"nctId":1406,"briefTitle":1407,"status":215,"phases":1408,"primaryCompletion":1409,"completion":1410,"start":1411,"enrollment":1202,"conditions":1412,"interventions":1414},"NCT05303688","Does Preventive Dexketoprofen Reduce Pain After Orthognathic Surgery",[80],"2018-10-01","2019-02-01","2018-03-01",[1413],"Pain, Postoperative",[1391,1415],"Steril Salin",{"intervention":1415,"totalTrials":83,"cells":1417},{"EARLY_PHASE1":1418,"PHASE1":1420,"PHASE2":1422,"PHASE3":1424,"PHASE4":1426,"NA":1428},{"trials":1419,"activeCount":87},[],{"trials":1421,"activeCount":87},[],{"trials":1423,"activeCount":87},[],{"trials":1425,"activeCount":87},[],{"trials":1427,"activeCount":87},[],{"trials":1429,"activeCount":87},[1430],{"nctId":1406,"briefTitle":1407,"status":215,"phases":1431,"primaryCompletion":1409,"completion":1410,"start":1411,"enrollment":1202,"conditions":1432,"interventions":1433},[80],[1413],[1391,1415],{"intervention":1435,"totalTrials":83,"cells":1436},"Silver diamine Fluoride 38%",{"EARLY_PHASE1":1437,"PHASE1":1439,"PHASE2":1441,"PHASE3":1443,"PHASE4":1445,"NA":1447},{"trials":1438,"activeCount":87},[],{"trials":1440,"activeCount":87},[],{"trials":1442,"activeCount":87},[],{"trials":1444,"activeCount":87},[],{"trials":1446,"activeCount":87},[],{"trials":1448,"activeCount":87},[1449],{"nctId":1450,"briefTitle":1451,"status":215,"phases":1452,"primaryCompletion":1453,"completion":1454,"start":1455,"enrollment":207,"conditions":1456,"interventions":1458},"NCT07447583","Traditional vs. Minimally Invasive Decay Treatments in Primary Molars: An 18-month Split-mouth Randomized Study",[80],"2024-08-30","2026-02-09","2024-08-01",[1457],"Dental Caries",[1435],{"intervention":1460,"totalTrials":83,"cells":1461},"Transamine 10% IV\u002FIM Solution for",{"EARLY_PHASE1":1462,"PHASE1":1464,"PHASE2":1466,"PHASE3":1468,"PHASE4":1470,"NA":1472},{"trials":1463,"activeCount":87},[],{"trials":1465,"activeCount":87},[],{"trials":1467,"activeCount":87},[],{"trials":1469,"activeCount":87},[],{"trials":1471,"activeCount":87},[],{"trials":1473,"activeCount":87},[1474],{"nctId":1475,"briefTitle":1476,"status":215,"phases":1477,"primaryCompletion":1478,"completion":1479,"start":1480,"enrollment":101,"conditions":1481,"interventions":1483},"NCT06434636","The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon Satisfaction",[80],"2025-05-05","2025-08-06","2024-12-01",[1482],"Middle Ear Disease",[1460,1484],"%0.9 Saline",{"intervention":1484,"totalTrials":83,"cells":1486},{"EARLY_PHASE1":1487,"PHASE1":1489,"PHASE2":1491,"PHASE3":1493,"PHASE4":1495,"NA":1497},{"trials":1488,"activeCount":87},[],{"trials":1490,"activeCount":87},[],{"trials":1492,"activeCount":87},[],{"trials":1494,"activeCount":87},[],{"trials":1496,"activeCount":87},[],{"trials":1498,"activeCount":87},[1499],{"nctId":1475,"briefTitle":1476,"status":215,"phases":1500,"primaryCompletion":1478,"completion":1479,"start":1480,"enrollment":101,"conditions":1501,"interventions":1502},[80],[1482],[1460,1484],{"intervention":1504,"totalTrials":83,"cells":1505},"MTA",{"EARLY_PHASE1":1506,"PHASE1":1508,"PHASE2":1510,"PHASE3":1512,"PHASE4":1514,"NA":1516},{"trials":1507,"activeCount":87},[],{"trials":1509,"activeCount":87},[],{"trials":1511,"activeCount":87},[],{"trials":1513,"activeCount":87},[],{"trials":1515,"activeCount":87},[],{"trials":1517,"activeCount":87},[1518],{"nctId":1519,"briefTitle":1520,"status":215,"phases":1521,"primaryCompletion":1522,"completion":1523,"start":1524,"enrollment":144,"conditions":1525,"interventions":1529},"NCT06795282","Post Operative Sensitivity of MTA Obturation",[],"2025-12-01","2025-12-15","2025-01-30",[1526,1527,1528],"Dental Pulp Disease","Endodontically Treated Teeth","Endodontic Disease",[1504],{"intervention":1531,"totalTrials":83,"cells":1532},"enteral nutrition + proton pump inhibitor",{"EARLY_PHASE1":1533,"PHASE1":1535,"PHASE2":1537,"PHASE3":1539,"PHASE4":1541,"NA":1543},{"trials":1534,"activeCount":87},[],{"trials":1536,"activeCount":87},[],{"trials":1538,"activeCount":87},[],{"trials":1540,"activeCount":87},[],{"trials":1542,"activeCount":87},[],{"trials":1544,"activeCount":87},[1545],{"nctId":1546,"briefTitle":1547,"status":423,"phases":1548,"primaryCompletion":1549,"completion":1550,"start":1551,"enrollment":1552,"conditions":1553,"interventions":1558},"NCT03098537","Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled Trial",[80],"2017-08-01","2017-12-01","2016-08-01",500,[1554,1555,1556,1557],"Enteral Nutrition","Gastro Intestinal Bleeding","Stress Ulcer Prophylaxis","Proton Pump Inhibitor",[1531],{"intervention":1560,"totalTrials":83,"cells":1561},"bladder wall thermotherapy with Mitomycin-c",{"EARLY_PHASE1":1562,"PHASE1":1564,"PHASE2":1566,"PHASE3":1568,"PHASE4":1570,"NA":1572},{"trials":1563,"activeCount":87},[],{"trials":1565,"activeCount":87},[],{"trials":1567,"activeCount":87},[],{"trials":1569,"activeCount":87},[],{"trials":1571,"activeCount":87},[],{"trials":1573,"activeCount":87},[1574],{"nctId":1575,"briefTitle":1576,"status":215,"phases":1577,"primaryCompletion":1578,"completion":1579,"start":1580,"enrollment":481,"conditions":1581,"interventions":1583},"NCT03694535","Intravesical Thermochemotherapy With Mitomycin-c",[80],"2015-02-28","2017-09-15","2012-01-01",[1582],"Bladder Cancer",[1560],{"intervention":1362,"totalTrials":83,"cells":1585},{"EARLY_PHASE1":1586,"PHASE1":1588,"PHASE2":1590,"PHASE3":1592,"PHASE4":1594,"NA":1596},{"trials":1587,"activeCount":87},[],{"trials":1589,"activeCount":87},[],{"trials":1591,"activeCount":87},[],{"trials":1593,"activeCount":87},[],{"trials":1595,"activeCount":87},[],{"trials":1597,"activeCount":87},[1598],{"nctId":1352,"briefTitle":1353,"status":423,"phases":1599,"primaryCompletion":1355,"completion":1356,"start":1357,"enrollment":1358,"conditions":1600,"interventions":1601},[80],[1360],[1362,1363,1364,365],{"intervention":1363,"totalTrials":83,"cells":1603},{"EARLY_PHASE1":1604,"PHASE1":1606,"PHASE2":1608,"PHASE3":1610,"PHASE4":1612,"NA":1614},{"trials":1605,"activeCount":87},[],{"trials":1607,"activeCount":87},[],{"trials":1609,"activeCount":87},[],{"trials":1611,"activeCount":87},[],{"trials":1613,"activeCount":87},[],{"trials":1615,"activeCount":87},[1616],{"nctId":1352,"briefTitle":1353,"status":423,"phases":1617,"primaryCompletion":1355,"completion":1356,"start":1357,"enrollment":1358,"conditions":1618,"interventions":1619},[80],[1360],[1362,1363,1364,365],{"intervention":1364,"totalTrials":83,"cells":1621},{"EARLY_PHASE1":1622,"PHASE1":1624,"PHASE2":1626,"PHASE3":1628,"PHASE4":1630,"NA":1632},{"trials":1623,"activeCount":87},[],{"trials":1625,"activeCount":87},[],{"trials":1627,"activeCount":87},[],{"trials":1629,"activeCount":87},[],{"trials":1631,"activeCount":87},[],{"trials":1633,"activeCount":87},[1634],{"nctId":1352,"briefTitle":1353,"status":423,"phases":1635,"primaryCompletion":1355,"completion":1356,"start":1357,"enrollment":1358,"conditions":1636,"interventions":1637},[80],[1360],[1362,1363,1364,365]]